Skip to main content
. 2021 Oct 28;11(10):e548. doi: 10.1002/ctm2.548

FIGURE 9.

FIGURE 9

A schematic illustrating the suppression of cell proliferation and increased CD8+ T cell response upon treatment of ESCC tumours with indomethacin. Indomethacin directly binds to ITGAV, promotes the SYVN1‐mediated degradation of ITGAV and modulates the downstream FAK/PI3K/AKT and TGFβ/SMAD2/3 signalling pathways